CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.4324
+0.0164 (3.94%)
Apr 27, 2026, 1:11 PM EDT - Market open
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $6.23 million as of April 27, 2026. Its market cap has decreased by -78.21% in one year.
Market Cap
6.23M
Enterprise Value
3.25M
1-Year Change
-78.21%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $6.23M, a decrease of -79.63%. That is a compound annual growth rate of -17.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 5.30M | -70.39% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.56M |
| Akari Therapeutics, | 6.56M |
| FibroBiologics | 6.45M |
| XTL Biopharmaceuticals | 6.33M |
| Purple Biotech | 6.23M |
| BioRestorative Therapies | 5.86M |
| Aptevo Therapeutics | 5.76M |
| Mustang Bio | 5.71M |